Mar 08, 2023 7:00am EST Promis Neurosciences to Present at the Oppenheimer 33rd Annual Healthcare Conference
Nov 14, 2022 7:00am EST ProMIS Neurosciences Announces Third Quarter 2022 Financial Results and Recent Highlights
Sep 13, 2022 7:00am EDT ProMIS Neurosciences appoints accomplished biopharmaceutical leader, Dr. Gail M. Farfel, as Chief Executive Officer
Aug 15, 2022 5:00pm EDT ProMIS Neurosciences Announces Second Quarter 2022 Financial and Operating Results
Aug 02, 2022 7:00am EDT ProMIS Neurosciences Presents at 2022 Alzheimer’s Association International Conference
Jul 27, 2022 7:00am EDT ProMIS Neurosciences to Present at 2022 Alzheimer’s Association International Conference